Skip to main content
. 2008 Mar 19;15(5):773–782. doi: 10.1128/CVI.00020-08

TABLE 3.

Subjects receiving AG-702 or control vaccine from whom immunogenicity data were obtained

AG-702 or peptide dose (μg) No. of subjects whose HSV serostatus was:
Negative HSV-2 positive and HSV-1 negative or positive
10 5 5
100 5 16
250 3 16
Peptide (4) 3 3
Total 16 40